Skip to main content
Erschienen in: European Surgery 1/2019

23.10.2018 | original article

Transanal total mesorectal excision in selected patients with “difficult pelvis”: a case–control study of “difficult” rectal cancer patients

verfasst von: S. S. Gordeyev, MD PhD, K. E. Dzhumabaev, Z. Z. Mamedli, N. A. Kozlov, Y. E. Surayeva, M. Y. Fedyanin, A. O. Rasulov

Erschienen in: European Surgery | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Summary

Background

Transanal total mesorectal excision (taTME) yields potential benefits for patients with a narrow pelvis and previous chemoradiotherapy by facilitating mobilization of the lower part of the mesorectum. The aim of this study was to investigate the role of taTME in patients with “difficult pelvis.”

Methods

This single-institution retrospective nonrandomized cohort study included patients with difficult pelvis who underwent either laparoscopic total mesorectal excision (lapTME) or taTME during 2013–2016. “Difficult pelvis” was defined as a combination of male gender, high body mass index (BMI; ≥25 mg/m2), and previous chemoradiotherapy. Main outcome measures included TME quality, rate of stapling anastomoses, operative time, and postoperative complications.

Results

In total, 26 patients underwent lapTME and 26 underwent taTME. The median BMI was 29.2 kg/m2 and 28.3 kg/m2 in the laparoscopic and transanal groups, respectively (p = 0.8). The median operative time was 270 and 295 min, respectively (p = 0.2). One (3.8%) patient died in the laparoscopic group, whereas no deaths occurred in the taTME group. The rate of grade III–IV complications was three (11.5%) vs. three (11.5%), respectively (p = 1.0). Grade 1 TME was observed in four (17.4%) vs. four (16%) patients, respectively (p = 1.0; per protocol). Stapling anastomosis was performed on 17 (68%) vs. 21(84%) patients, respectively (p = 0.2). The median follow-up was 28.2 months. There was one case (3.8%) of distant failure in each group and one (3.8%) patient in the laparoscopic group developed a local recurrence.

Conclusion

In rectal cancer patients with difficult pelvis, taTME may lead to higher rates of stapling anastomoses without compromising other surgical outcomes. We did not find any differences in specimen quality or other surgical outcomes between the two groups.
Literatur
1.
Zurück zum Zitat Deijen C, Tsai A, Koedam T, Helbach MV, Sietses C, Lacy A, et al. Clinical outcomes and case volume effect of transanal total mesorectal excision for rectal cancer: a systematic review. Tech Coloproctol. 2016;20(12):811–24.CrossRef Deijen C, Tsai A, Koedam T, Helbach MV, Sietses C, Lacy A, et al. Clinical outcomes and case volume effect of transanal total mesorectal excision for rectal cancer: a systematic review. Tech Coloproctol. 2016;20(12):811–24.CrossRef
2.
Zurück zum Zitat Lacy AM, Tasende MM, Delgado S, Fernandez-Hevia M, Jimenez M, De Lacy B, et al. Transanal total mesorectal excision for rectal cancer: outcomes after 140 patients. J Am Coll Surg. 2015;221(2):415–23.CrossRef Lacy AM, Tasende MM, Delgado S, Fernandez-Hevia M, Jimenez M, De Lacy B, et al. Transanal total mesorectal excision for rectal cancer: outcomes after 140 patients. J Am Coll Surg. 2015;221(2):415–23.CrossRef
3.
Zurück zum Zitat Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, et al. Transanal total mesorectal excision: international registry results of the first 720 cases. Ann Surg. 2017;266(1):111–7.CrossRef Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, et al. Transanal total mesorectal excision: international registry results of the first 720 cases. Ann Surg. 2017;266(1):111–7.CrossRef
4.
Zurück zum Zitat Atallah S. Transanal total mesorectal excision: full steam ahead. Tech Coloproctol. 2015;19(2):57–61.CrossRef Atallah S. Transanal total mesorectal excision: full steam ahead. Tech Coloproctol. 2015;19(2):57–61.CrossRef
5.
Zurück zum Zitat Rouanet P, Mourregot A, Azar CC, Carrere S, Gutowski M, Quenet F, et al. Transanal endoscopic proctectomy: an innovative procedure for difficult resection of rectal tumors in men with narrow pelvis. Dis Colon Rectum. 2013;56(4):408–15.CrossRef Rouanet P, Mourregot A, Azar CC, Carrere S, Gutowski M, Quenet F, et al. Transanal endoscopic proctectomy: an innovative procedure for difficult resection of rectal tumors in men with narrow pelvis. Dis Colon Rectum. 2013;56(4):408–15.CrossRef
6.
Zurück zum Zitat Deijen CL, Velthuis S, Tsai A, Mavroveli S, de Lange-de Klerk ES, Sietses C, et al. COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer. Surg Endosc. 2016;30(8):3210–5.CrossRef Deijen CL, Velthuis S, Tsai A, Mavroveli S, de Lange-de Klerk ES, Sietses C, et al. COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer. Surg Endosc. 2016;30(8):3210–5.CrossRef
7.
Zurück zum Zitat Kang SB, Park JW, Jeong SY, Nam BH, Choi HS, Kim DW, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol. 2010;11(7):637–45.CrossRef Kang SB, Park JW, Jeong SY, Nam BH, Choi HS, Kim DW, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol. 2010;11(7):637–45.CrossRef
8.
Zurück zum Zitat Jeong SY, Park JW, Nam BH, Kim S, Kang SB, Lim SB, et al. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncol. 2014;15(7):767–74.CrossRef Jeong SY, Park JW, Nam BH, Kim S, Kang SB, Lim SB, et al. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncol. 2014;15(7):767–74.CrossRef
9.
Zurück zum Zitat Oh SJ, Shin JY. Risk factors of circumferential resection margin involvement in the patients with extraperitoneal rectal cancer. J Korean Surg Soc. 2012;82(3):165–71.CrossRef Oh SJ, Shin JY. Risk factors of circumferential resection margin involvement in the patients with extraperitoneal rectal cancer. J Korean Surg Soc. 2012;82(3):165–71.CrossRef
10.
Zurück zum Zitat Ogiso S, Yamaguchi T, Hata H, Fukuda M, Ikai I, Yamato T, et al. Evaluation of factors affecting the difficulty of laparoscopic anterior resection for rectal cancer:“narrow pelvis” is not a contraindication. Surg Endosc. 2011;25(6):1907–12.CrossRef Ogiso S, Yamaguchi T, Hata H, Fukuda M, Ikai I, Yamato T, et al. Evaluation of factors affecting the difficulty of laparoscopic anterior resection for rectal cancer:“narrow pelvis” is not a contraindication. Surg Endosc. 2011;25(6):1907–12.CrossRef
11.
Zurück zum Zitat Rasulov A, Mamedli Z, Gordeyev S, Kozlov N, Dzhumabaev H. Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer. Tech Coloproctol. 2016;20(4):227–34.CrossRef Rasulov A, Mamedli Z, Gordeyev S, Kozlov N, Dzhumabaev H. Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer. Tech Coloproctol. 2016;20(4):227–34.CrossRef
12.
Zurück zum Zitat Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH, et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol. 2002;20(7):1729–34.CrossRef Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH, et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol. 2002;20(7):1729–34.CrossRef
13.
Zurück zum Zitat Dindo D, Demartines N, Clavien P‑A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205.CrossRef Dindo D, Demartines N, Clavien P‑A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205.CrossRef
14.
Zurück zum Zitat Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–96.CrossRef Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–96.CrossRef
15.
Zurück zum Zitat Ma B, Gao P, Song Y, Zhang C, Zhang C, Wang L, et al. Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision. BMC Cancer. 2016;16:380.CrossRef Ma B, Gao P, Song Y, Zhang C, Zhang C, Wang L, et al. Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision. BMC Cancer. 2016;16:380.CrossRef
16.
Zurück zum Zitat Guarnero V, Hahnloser D. Transanal surgery: today’s and future applications. Ann Laparosc Endosc Surg. 2017;2(1):5.CrossRef Guarnero V, Hahnloser D. Transanal surgery: today’s and future applications. Ann Laparosc Endosc Surg. 2017;2(1):5.CrossRef
17.
Zurück zum Zitat Wu A, He G, Wang L, Dong Q, Liu X, Li Y, et al. Short-term outcome of transanal total mesorectal excision for male low rectal cancer patients with“difficult pelvis”: a single center report from Peking University Cancer Hospital. Zhonghua Wei Chang Wai Ke Za Zhi. 2018;21(6):646–53.PubMed Wu A, He G, Wang L, Dong Q, Liu X, Li Y, et al. Short-term outcome of transanal total mesorectal excision for male low rectal cancer patients with“difficult pelvis”: a single center report from Peking University Cancer Hospital. Zhonghua Wei Chang Wai Ke Za Zhi. 2018;21(6):646–53.PubMed
18.
Zurück zum Zitat Lewis WG, Martin IG, Williamson ME, Stephenson BM, Holdsworth PJ, Finan PJ, et al. Why do some patients experience poor functional results after anterior resection of the rectum for carcinoma? Dis Colon Rectum. 1995;38(3):259–63.CrossRef Lewis WG, Martin IG, Williamson ME, Stephenson BM, Holdsworth PJ, Finan PJ, et al. Why do some patients experience poor functional results after anterior resection of the rectum for carcinoma? Dis Colon Rectum. 1995;38(3):259–63.CrossRef
19.
Zurück zum Zitat Matzel KE, Stadelmaier U, Muehldorfer S, Hohenberger W. Continence after colorectal reconstruction following resection: impact of level of anastomosis. Int J Colorectal Dis. 1997;12(2):82–7.CrossRef Matzel KE, Stadelmaier U, Muehldorfer S, Hohenberger W. Continence after colorectal reconstruction following resection: impact of level of anastomosis. Int J Colorectal Dis. 1997;12(2):82–7.CrossRef
20.
Zurück zum Zitat van der Pas MH, Haglind E, Cuesta MA, Furst A, Lacy AM, Hop WC, et al. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. 2013;14(3):210–8.CrossRef van der Pas MH, Haglind E, Cuesta MA, Furst A, Lacy AM, Hop WC, et al. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. 2013;14(3):210–8.CrossRef
21.
Zurück zum Zitat Jayne DG, Guillou PJ, Thorpe H, Quirke P, Copeland J, Smith AM, et al. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3‑year results of the UK MRC CLASICC Trial Group. J Clin Oncol. 2007;25(21):3061–8.CrossRef Jayne DG, Guillou PJ, Thorpe H, Quirke P, Copeland J, Smith AM, et al. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3‑year results of the UK MRC CLASICC Trial Group. J Clin Oncol. 2007;25(21):3061–8.CrossRef
22.
Zurück zum Zitat Agha A, Furst A, Iesalnieks I, Fichtner-Feigl S, Ghali N, Krenz D, et al. Conversion rate in 300 laparoscopic rectal resections and its influence on morbidity and oncological outcome. Int J Colorectal Dis. 2008;23(4):409–17.CrossRef Agha A, Furst A, Iesalnieks I, Fichtner-Feigl S, Ghali N, Krenz D, et al. Conversion rate in 300 laparoscopic rectal resections and its influence on morbidity and oncological outcome. Int J Colorectal Dis. 2008;23(4):409–17.CrossRef
23.
Zurück zum Zitat Taylor EF, Thomas JD, Whitehouse LE, Quirke P, Jayne D, Finan PJ, et al. Population-based study of laparoscopic colorectal cancer surgery 2006–2008. Br J Surg. 2013;100(4):553–60.CrossRef Taylor EF, Thomas JD, Whitehouse LE, Quirke P, Jayne D, Finan PJ, et al. Population-based study of laparoscopic colorectal cancer surgery 2006–2008. Br J Surg. 2013;100(4):553–60.CrossRef
24.
Zurück zum Zitat Tekkis PP, Senagore AJ, Delaney CP. Conversion rates in laparoscopic colorectal surgery: a predictive model with, 1253 patients. Surg Endosc. 2005;19(1):47–54.CrossRef Tekkis PP, Senagore AJ, Delaney CP. Conversion rates in laparoscopic colorectal surgery: a predictive model with, 1253 patients. Surg Endosc. 2005;19(1):47–54.CrossRef
Metadaten
Titel
Transanal total mesorectal excision in selected patients with “difficult pelvis”: a case–control study of “difficult” rectal cancer patients
verfasst von
S. S. Gordeyev, MD PhD
K. E. Dzhumabaev
Z. Z. Mamedli
N. A. Kozlov
Y. E. Surayeva
M. Y. Fedyanin
A. O. Rasulov
Publikationsdatum
23.10.2018
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 1/2019
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-018-0558-5

Weitere Artikel der Ausgabe 1/2019

European Surgery 1/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.